Resmed 

$228.51
499
+$0.22+0.1% Friday 17:29

統計

當日最高
230.11
當日最低
226.38
52週高點
240
52週低點
132.67
成交量
65.6
平均成交量
-
市值
33.29B
本益比
0.42
股息殖利率
1.05%
股息
2.4

即將到來

股息

1.05%股息殖利率
Mar 26
$0.6
Dec 25
$0.6
Sep 25
$0.6
Jun 25
$0.53
Mar 25
$0.53
10年成長
6.66%
5年成長
8.18%
3年成長
9.26%
1年成長
6.19%

財報

30Apr預期
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
下一步
2.05
2.31
2.56
2.81
預期EPS
2.807471
實際EPS
不適用

財務

27.22%利潤率
有盈利
2019
2020
2021
2022
2023
2024
10.29B營收
2.8B淨利

分析師評級

$293.56平均目標價
最高預估為 340.00。
來自過去6個月內的 9 則評分。這不是投資建議。
買入
56%
持有
44%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 0KW4.LSE 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Show more...
執行長
Mr. Michael J. Farrell BE, MBA, SM
員工
10600
國家
GB
ISIN
US7611521078

上市

0 Comments

分享你的想法

FAQ

Resmed 今天的股價是多少?
0KW4.LSE 目前價格為 $228.51 USD,過去 24 小時上漲了 +0.1%。在圖表上更密切關注 Resmed 股價表現。
Resmed 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Resmed 的股票以代號 0KW4.LSE 進行交易。
Resmed 的股價在上漲嗎?
0KW4.LSE 股票較上週上漲 +2.44%,本月下跌 -4.65%,過去一年 Resmed 上漲 +10.09%。
Resmed 的市值是多少?
今天 Resmed 的市值為 33.29B
Resmed 下一次財報日期是什麼時候?
Resmed 將於 April 30, 2026 公布下一次財報。
Resmed 上一季度的財報如何?
0KW4.LSE 上一季度的財報為每股 2.81 USD,預估為 2.74 USD,帶來 +2.38% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Resmed 去年的營收是多少?
Resmed 去年的營收為 10.29BUSD。
Resmed 去年的淨利是多少?
0KW4.LSE 去年的淨收益為 2.8BUSD。
Resmed 會發放股息嗎?
是的,0KW4.LSE 的股息每 每季 發放一次。每股最新股息為 0.6 USD。截至今日,股息殖利率(FWD)% 為 1.05%。
Resmed 有多少名員工?
截至 April 11, 2026,公司共有 10,600 名員工。
Resmed 位於哪個產業?
Resmed從事於Industrials產業。
Resmed 何時完成拆股?
Resmed 上次拆股發生於 August 31, 2010,比例為 2:1。
Resmed 的總部在哪裡?
Resmed 的總部位於 GB 的 San Diego。